Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

01/08/2017 05:30

Aug 1 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             24.97               26.23           101.70     
                 (-4.8 pct)          (-5.1 pct)       (+0.2 pct)   
  Operating          7.65                8.10            26.80     
                 (-5.5 pct)          (-12.3 pct)      (-12.7 pct)  
  Recurring          7.81                8.22            27.00     
                 (-4.9 pct)          (-12.2 pct)      (-12.9 pct)  
  Net                5.46                5.80            19.10     
                 (-5.7 pct)          (-8.0 pct)       (-13.2 pct)  
  EPS            133.81 yen          140.05 yen       470.49 yen   
  Ann Div                            150.00 yen       150.00 yen   
  -Q2 div                             75.00 yen        75.00 yen   
  -Q4 div                             75.00 yen        75.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T  
  ((Tokyo Headline News Desk +813 6441 1812))